Technical Analysis for RMTI - Rockwell Medical, Inc.

Grade Last Price % Change Price Change
grade D 3.47 10.16% 0.32
RMTI closed up 10.16 percent on Friday, January 18, 2019, on 75 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical RMTI trend table...

Date Alert Name Type % Chg
Jan 18 Crossed Above 50 DMA Bullish 0.00%
Jan 18 180 Bullish Setup Bullish Swing Setup 0.00%
Jan 18 Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Stochastic Reached Overbought Strength 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 50 DMA Resistance Bearish 10.16%
Jan 17 Wide Bands Range Expansion 10.16%
Jan 16 50 DMA Resistance Bearish 7.76%

Older signals for RMTI ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis (HD). Its products are used to cleanse patients' blood and replace nutrients lost during the kidney dialysis process. The company manufactures, sells, delivers, and distributes HD concentrates, such as CitraPure citric-acid concentrate, Dri-Sate dry acid, Renal Pure liquid acid concentrate, dry acid concentrate mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. It also intends to offer Calcitriol, a generic active vitamin D for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company is also developing Soluble Ferric Pyrophosphate, which is in two Phase III clinical trials for iron therapy treatment in CKD-HD patients. Rockwell Medical, Inc. sells its products directly to hemodialysis providers, as well as through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan.
Is RMTI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.92
52 Week Low 2.19
Average Volume 251,493
200-Day Moving Average 4.3932
50-Day Moving Average 3.2168
20-Day Moving Average 2.8975
10-Day Moving Average 3.174
Average True Range 0.2591
ADX 23.54
+DI 27.2223
-DI 14.2247
Chandelier Exit (Long, 3 ATRs ) 2.7727
Chandelier Exit (Short, 3 ATRs ) 2.9673
Upper Bollinger Band 3.5715
Lower Bollinger Band 2.2235
Percent B (%b) 0.92
BandWidth 46.522865
MACD Line 0.0427
MACD Signal Line -0.0365
MACD Histogram 0.0792
Fundamentals Value
Market Cap 179.54 Million
Num Shares 51.7 Million
EPS -0.42
Price-to-Earnings (P/E) Ratio -8.26
Price-to-Sales 5.78
Price-to-Book 7.13
PEG Ratio -0.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.07
Resistance 3 (R3) 4.03 3.79 3.97
Resistance 2 (R2) 3.79 3.64 3.81 3.94
Resistance 1 (R1) 3.63 3.54 3.71 3.67 3.90
Pivot Point 3.39 3.39 3.43 3.41 3.39
Support 1 (S1) 3.23 3.24 3.31 3.27 3.04
Support 2 (S2) 2.99 3.14 3.01 3.00
Support 3 (S3) 2.83 2.99 2.97
Support 4 (S4) 2.87